As New Jersey and Pennsylvania Depuy hip recall attorneys, we have been posting various bits of information regarding the Depuy hip recall and its effect on recipients of the implant. We hope these posts have been helpful to not only patients who have experienced implant failure, but to all Depuy hip recall patients, regardless of whether or not they have experienced pain or symptoms associated with the DePuy hip implant failure.
Did the FDA Have Anything to Do With the Recall?
Recently a Depuy hip implant patient asked us, “What does the federal government have to say about the Depuy hip implant recall?” As many know, medical devices, such as artificial hips, prosthesis, knee joint replacements, and other implants, are supposed to be regulated by the Food and Drug administration (FDA). According to its website, the FDA is charged with responsibility for:
“protecting the public health by assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.”
Despite this responsibility, the FDA has not done much regarding the recall since July 17, 2010, the date they posted information on specific recalled devices. The recall contained DePuy technical data that listed all of the various sized component parts of the DePuy ASR hip replacement system. As for the reason for the recall, the FDA quoted Depuy, stating that the recall was caused by “notification to clinicians of new revision rate data/information regarding use of the device.” What does that mean? It means that DePuy and the FDA were receiving complaints that the hip implant was failing at an alarming rate, causing the necessity for revision surgeries to rise to a new and unacceptable level. These complaints started coming in shortly after DePuy was granted approval to market their device in the United States in 2003.
DePuy Hip Recall Attorneys in New Jersey and Philadelphia
Unfortunately, the FDA has not provided any additional information to patients about what to do next. In fact, the FDA website refers all inquiries back to Depuy’s home office in Indiana. As New Jersey Depuy hip recall attorneys, we urge the FDA to be more diligent in its reporting of consumer complaints regarding medical devices. The device was approved for use in 2003, and was on the market for 7 years before it was finally recalled. Had the complaints been investigated sooner, perhaps surgeons and potential Depuy hip implant patients would have thought twice about using this defective hip replacement product.
If you are the recipient of a DePuy ASR XL Acetabular hip implant system, or an ASR XL Hip Resurfacing System, contact the Mininno Law Office for a free case evaluation. You may also call for a free consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia. Our defective product attorneys are skilled in earning full and fair compensation for victims of negligent and defective manufacturing.
Today we are reporting about the South Jersey Health Care Center located in Camden, New Jersey. This is a nursing home that has 120 long term care patient beds. In a two year period, from November 2008 until October 2010, this nursing home was inspected on two separate occasions. During those inspections, the nursing home was cited for 16 separate violations. These violations included failure to meet proper safety code standards, lack of proper housekeeping and maintenance services, and food and nutritional issues. Many of the violations were found to occur often, and at least one of the violations was considered immediate jeopardy to residents’ health and safety.
Whistleblower and qui tam claims do essentially the same thing; they allow employees to file lawsuits against their employers for fraud or other illegal practices. Many times, especially in the healthcare industry, companies engage in fraudulent advertising to increase popularity of a product. Pharmaceutical companies are largely guilty of committing this type of fraud. Creating false or untested uses for a certain drug, or offering physicians large amounts of money (kickbacks) to recommend and prescribe certain drugs is very much illegal, and equally as dangerous.
Today, we are reporting on the Stratford Nursing & Convalescent Center located in Stratford, New Jersey. The latest published report shows all of the violations found during the routine inspections for the two year period between November 2008 and October 2010. The Stratford Nursing & Convalescent Center had 33 cited nursing home violations on the two combined inspection dates. The facility’s citations included safety code violations, life safety code standard violations, and others related to abuse and neglect. The level of violations were mainly rated as being pattern or widespread violations, with at least four considered to cause immediate jeopardy to the residents health or safety. Stratford’s ratings are a sure cause for concern, and it is quite clear that immediate corrective action needs to be taken. The facility’s noncompliance with one or more standards has caused, or is likely to cause, serious injury, harm, impairment, or death to a patient or resident. 
White House aides have provided that President Obama is strongly opposed to placing caps on damages for injured patients, but would be open to utilizing other avenues of resolution, such as “health courts” or special arbitration systems. 
Bob Lugton, of Brisbane, Australia, was declared the first “Aussie” to join the DePuy hip recall lawsuit. Mr. Lugton filed suit when his DePuy hip implant failed only 18 months after having been implanted. As stated in previous posts, DePuy and Johnson & Johnson claimed that their hip implant would last as long as 20 years, so Mr. Lugton was a very unhappy man after his brand new hip failed so quickly. Like most DePuy hip recall patients, Mr. Lugton was also found to have cobalt and other metals leaking into his body from the wear and tear of his hardware. When asked why he joined the DePuy hip recall lawsuit, Mr. Lugton reportedly stated, “This is not for financial reasons”, but to let other people know of the devastating effects of toxic cobalt and chromium levels on his health and welfare.
As a family member of a nursing home resident, it is important to be aware of the signs and symptoms of nursing home neglect and abuse. Keep a close watch not only on your loved one, but on the facility in it’s entirety, for the following signs of neglect:
Chad Aders, 37, was prescribed a Duragesic patch in the ER by Dr. Bryan Lilly in July of 2004. The patch contains a very potent narcotic called Fentanyl that enters the bloodstream through the skin. Dr. Lilly prescribed 75 micrograms of the drug which is well over the manufacturer’s reccomendations. Aders took the prescription to the drug store, got it filled, applied the patch as he was told, and went to bed. He was found dead in his bed the following day. His children were seven, eight, and seventeen. 
We thank Mr. Schaberick for his comment on DePuy and Johnson & Johnson, and we do not completely disagree. However, our own research has shown that not all doctors who show up on the DePuy website have accepted honorarium or other monetary benefits to select the DePuy hip implant for their patients. However, as was pointed out by Mr. Schaberick, many of the orthopaedic surgeons did in fact receive significant monies and benefits from DePuy and Johnson & Johnson in return for selecting the ASR XL Acetabular complete or resurfacing implant systems. Mr. Schaberick is also correct that DePuy and Johnson & Johnson paid millions of dollars over the last several years because of violations of federal anti-kick-back laws.